MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-TS-26-0000883
Apogen Remedies Private Limited - pharma in Siddipet, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹8.63 Cr
▼ 35% YoY
Net profit · FY 2025
₹1.4 Cr
Net margin 16.2%
EBITDA · FY 2025
₹2.69 Cr
EBITDA margin 31.2%
Authorised capital
₹15 Cr
Registered with MCA
Paid-up capital
₹14.8 Cr
Issued & subscribed
Open charges
₹5 Cr
Satisfied ₹5 Cr
Company age
15 yrs
Est. 2011
Employees · EPFO
33
Provident fund records
About Apogen Remedies Private Limited
Data last updated:
Apogen Remedies Private Limited is a private limited company based in Siddipet, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 05 July 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2011PTC075363. Its GSTIN is 36AAJCA6339G2ZJ (Telangana). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹15 Cr and a paid-up capital of ₹14.8 Cr. It is led by directors including Vikram Bery and Bala Murali Krishna Thippabhotla.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 321 Biotech Park, Siddipet, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹8.63 Cr, a decline of 35% compared to the previous year. For the same year it recorded a net profit of ₹1.4 Cr (net margin 16.2%) and EBITDA of ₹2.69 Cr (EBITDA margin 31.2%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 930% over five years.
The company has about 33 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Apogen. As per MCA filings, the company has open charges of ₹5 Cr and satisfied charges of ₹5 Cr on record.
Apogen Remedies Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-26-0000883). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website apogen.in.
Company details
CIN U24232TG2011PTC075363
Registration Number 075363
Incorporation Date 05 July 2011
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TS-26-0000883
CIN history
Apogen Remedies has one previous CIN (Corporate Identification Number): U24232AP2011PTC075363. The current CIN is U24232TG2011PTC075363, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2011PTC075363 | Current |
| U24232AP2011PTC075363 | Previous |
Key People
Vikram Bery Director Bala Murali Krishna Thippabhotla Director Bhanu Prasad Kommineni Director Recognitions & Rankings of Apogen Remedies
Contact details
Apogen Remedies Private Limited's registered office is in Siddipet, Telangana. Its website is apogen.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressP No. 55/A Survey # 321 Biotech Park Phase – III (Tsiic) Karkapatla Village Markook Man, Dal, Siddipet, Telangana, India – 502281
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Apogen Remedies Private Limited, buy the company report.
Comprehensive company report
Apogen Remedies Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Apogen Remedies is support service to organizations. In detail, this covers other support services to organizations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| N | Support service to Organizations | N7 | Other support services to organizations |
To see the full business activity and turnover split of Apogen Remedies Private Limited, buy the company report.
Financials of Apogen Remedies Private Limited
FY 2024 filings availableApogen Remedies Private Limited reported revenue of ₹8.63 Cr (down 35% YoY) for FY 2025.
Revenue · FY 2025
₹8.63 Cr ▼ 35%
Net profit · FY 2025
₹1.4 Cr margin 16.2%
EBITDA · FY 2025
₹2.69 Cr margin 31.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 35%
3 years · compounded
▲ 7%
5 years · compounded
▲ 930%
EBITDA CAGR growth
1 year
▲ 31%
3 years · compounded
▼ 3%
5 years · compounded
▲ 125%
Revenue fell 35% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 930%. EBITDA rose 31% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.69 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.4 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 31.2% | ||||
| Net Profit Margin | 16.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Apogen Remedies Private Limited, buy the company report.
Board of directors of Apogen Remedies Private Limited
Apogen Remedies has 4 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vikram Bery | Director | 19 Jul 2019 | 7 Years 3 Months | Current |
| Bala Murali Krishna Thippabhotla Also directs: Bago Laboratories Private Limited, Exarmed Pharma LLP | Director | 19 Jul 2019 | 7 Years 3 Months | Current |
| Bhanu Prasad Kommineni | Director | 05 Jul 2011 | 15 Years 3 Months | Current |
| Tamma Raghava Srinivasa Reddy Also directs: Aushadi Health Care Private Limited | Director | 05 Jul 2011 | 15 Years 3 Months | Current |
Auditor
Apogen Remedies Private Limited is audited by NSVR & ASSOCIATES LLP for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| NSVR & ASSOCIATES LLP | FY 2022 | 008801S/S200060 |
Shareholding
The shareholding of Apogen Remedies Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Apogen Remedies Private Limited, buy the company report.
Charges & borrowings
Open charges
₹5 Cr
Satisfied charges
₹5 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 07 Feb 2020 | 100324009 | Hdfc Bank Limited | ₹5 Cr | Open | |
| 30 Mar 2016 | 100029097 | Others | ₹5 Cr | Satisfied |
To see the full charge records of Apogen Remedies Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Apogen Remedies Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Apogen Remedies Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Apogen Remedies has 1 associated company. This group structure data is as of FY 2022. The table lists each entity with its relationship and holding.
1
Associated companies
Employees & EPFO
Apogen Remedies Private Limited has a workforce of 33 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
Employee count
33
Active EPFO establishments
1
GST
Apogen Remedies has 3 GST registrations: 1 active and 2 cancelled or inactive.
Total GSTINs
3
Active
1
Cancelled / inactive
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAJCA6339G2ZJ | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Apogen Remedies Private Limited, buy the company report.
Recent activity
Apogen Remedies Private Limited has 11 board changes on record since 2011: 4 appointments and 7 cessations. The latest: Abhishek Shukla ceased to be Company Secretary on 31 May 2025.
Ceased
Abhishek Shukla ceased to be Company Secretary.
AGM
Apogen Remedies Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Apogen Remedies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Charges
A charge registered on 30 Mar 2016 via Charge ID 100029097 with Others was fully satisfied on 14 Sep 2023.
Ceased
Bhanu Prasad Kommineni ceased to be Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 5.00 Cr with Charge ID 100324009 was registered on 07 Feb 2020.
Ceased
Bala Murali Krishna Thippabhotla ceased to be Additional Director.
Ceased
Vikram Bery ceased to be Additional Director.
Appointed
Bala Murali Krishna Thippabhotla was appointed as Director.
Ceased
Kavitha Chundu ceased to be Director.
Ceased
Venkata Poorna Chandramouli Sastry Teladevalapalli ceased to be Director.
Appointed
Vikram Bery was appointed as Director.
5 earlier events are in the company report.
Frequently asked questions
Apogen Remedies is an active private limited company based in Siddipet, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 05 July 2011 (15+ years old) and is registered under CIN U24232TG2011PTC075363.
Apogen Remedies has 4 current directors:
- Vikram Bery - Director
- Bala Murali Krishna Thippabhotla - Director
- Bhanu Prasad Kommineni - Director
- Tamma Raghava Srinivasa Reddy - Director
The latest financial statements of Apogen Remedies on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Apogen Remedies is 36AAJCA6339G2ZJ, registered in Telangana. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Apogen Remedies is U24232TG2011PTC075363. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Apogen Remedies was incorporated on 05 July 2011, making it 15+ years old. It is registered with the Registrar of Companies, Hyderabad.
Abhishek Shukla ceased to be Company Secretary on 31 May 2025. Bhanu Prasad Kommineni ceased to be Director on 09 Sep 2020. Bala Murali Krishna Thippabhotla ceased to be Additional Director on 27 Sep 2019. Apogen Remedies has 11 board changes on record in total.
Yes, Apogen Remedies is registered as a small enterprise under Udyam registration (number: UDYAM-TS-26-0000883).
Apogen Remedies can be reached through the website apogen.in. Its registered office is in Siddipet, Telangana, India.
The registered office of Apogen Remedies is at P No. 55A Survey # 321 Biotech Park Phase – III Tsiic Karkapatla Village Markook Man, Dal, Siddipet, Telangana, India – 502281.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages